Polymorphisms and haplotypes of the NBS1 gene in childhood acute leukaemia

European Journal of Cancer

Volumn 44, Issue 15, 2008, Pages 2226-2232

  Mosor, Maria ^a   Ziółkowska, Iwona ^a   Januszkiewicz Lewandowska, Danuta ^a,b   Nowak, Jerzy ^a  

^a INSTITUTE OF HUMAN GENETICS   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Childhood leukaemia; Haplotype; NBS1 gene; Polymorphism

Indexed keywords

NIBRIN;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CANCER RISK; CANCER SUSCEPTIBILITY; CHILD; CONTROLLED STUDY; DNA POLYMORPHISM; DNA REPAIR; DOUBLE STRANDED DNA BREAK; GENE; GENE MUTATION; GENOTYPE; GERM LINE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; NBS1 GENE; PRIORITY JOURNAL;

ACUTE DISEASE; ADOLESCENT; CELL CYCLE PROTEINS; CHILD; CHILD, PRESCHOOL; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INFANT; LEUKEMIA; NEOPLASM PROTEINS; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC;

EID: 53049107194     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.06.026     Document Type: Article

References (35)

1. Carney J.P., Maser R.S., Olivares H., et al. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell 93 (1998) 477-486
2. Tauchi H., Matsuura S., Kobayashi J., Sakamoto S., and Komatsu K. Nijmegen breakage syndrome gene, NBS1, and molecular links to factors for genome stability. Oncogene 21 (2002) 8967-8980
3. Buscemi G., Savio C., Zannini L., et al. Chk2 activation dependence on Nbs1 after DNA damage. Mol Cell Biol 21 (2001) 5214-5222
4. Girard P.M., Riballo E., Begg A.C., Waugh A., and Jeggo P.A. Nbs1 promotes ATM dependent phosphorylation events including those required for G1/S arrest. Oncogene 21 (2002) 4191-4199
5. Uziel T., Lerenthal Y., Moyal L., Andegeko Y., Mittelman L., and Shiloh Y. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J 22 (2003) 5612-5621
6. Lee J.H., and Paull T.T. Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science 304 (2004) 93-96
7. Matsuura S., Tauchi H., Nakamura A., et al. Positional cloning of the gene for Nijmegen breakage syndrome. Nat Genet 19 (1998) 179-181
8. Varon R., Vissinga C., Platzer M., et al. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 93 (1998) 467-476
9. Varon R., Seemanova E., Chrzanowska K., et al. Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three Slav populations. Eur J Hum Genet 8 (2000) 900-902
10. Semanová E., Jarolim P., Seeman P., et al. Cancer risk of heterozygotes with the NBN founder mutation. J Natl Cancer Inst 99 (2007) 1875-1880
11. Steffen J., Varon R., Mosor M., et al. Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland. Int J Cancer 111 1 (2004) 67-71
12. Steffen J., Nowakowska D., Niwińska A., et al. Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland. Int J Cancer 119 (2006) 472-475
13. Cybulski C., Gorski B., Debniak T., et al. NBS1 is a prostate cancer susceptibility gene. Cancer Res 64 (2004) 1215-1219
14. Chrzanowska K.H., Piekutowska-Abramczuk D., Popowska E., et al. Carrier frequency of mutation 657del5 in the NBS1 gene in a population of Polish pediatric patients with sporadic lymphoid malignancies. Int J Cancer 118 (2006) 1269-1274
15. Stanulla M., Stumm M., Dieckvoss B.O., et al. No evidence for a major role of heterozygous deletion 657del5 within the NBS1 gene in the pathogenesis of non-Hodgkin's lymphoma of childhood and adolescence. Br J Haematol 109 (2000) 117-120
16. Hama S., Matsuura S., Tauchi H., et al. Absence of mutations in the NBS1 gene in B-cell malignant lymphoma patients. Anticancer Res 20 (2000) 1897-1900
17. Stumm M., von Ruskowsky A., Siebert R., et al. No evidence for deletions of the NBS1 gene in lymphomas. Cancer Genet Cytogenet 126 (2001) 60-62
18. Cerosaletti K.M., Morrison V.A., Sabath D.E., Willerford D.M., and Concannon P. Mutations and molecular variants of the NBS1 gene in non-Hodgkin lymphoma. Genes Chromosomes Cancer 35 (2002) 282-286
19. Mosor M., Ziółkowska I., Pernak-Schwarz M., Januszkiewicz-Lewandowska D., and Nowak J. Association of the heterozygous germline I171V mutation of the NBS1 gene with childhood acute lymphoblastic leukemia. Leukemia 20 (2006) 1454-1456
20. Ziółkowska I., Mosor M., Wierzbicka M., Rydzanicz M., Pernak-Schwarz M., and Nowak J. Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene. Cancer Sci 98 (2007) 1701-1705
21. Nowak J., Mosor M., Ziółkowska I., et al. Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumors. Eur J Cancer 44 (2008) 627-630
22. Millikan R.C., Player J.S., Decotret A.R., Tse C.K., and Keku T. Polymorphisms in DNA repair genes, medical exposure to ionizing radiation, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14 (2005) 2326-2334
23. Lu J., Wei Q., Bondy M.L., et al. Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women <or=55 years. Carcinogenesis 27 (2006) 2209-2216
24. Sanyal S., Festa F., Sakano S., et al. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25 (2004) 729-734
25. Medina P.P., Ahrendt S.A., Pollan M., Fernandez P., Sidransky D., and Sanchez-Cespedes M. Screening of homologous recombination gene polymorphisms in lung cancer patients reveals an association of the NBS1-185Gln variant and p53 gene mutations. Cancer Epidemiol Biomarkers Prev 12 (2003) 699-704
26. Zienolddiny S., Campa D., Lind H., et al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 27 (2006) 560-567
27. Auranen A., Song H., Waterfall C., et al. Polymorphisms in DNA repair genes and epithelial ovarian cancer risk. Int J Cancer 117 (2005) 611-618
28. Kuschel B., Auranen A., McBride S., et al. Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 11 (2002) 1399-1407
29. Lan Q., Shen M., Berndt S.I., et al. Smoky coal exposure, NBS1 polymorphisms, p53 protein accumulation, and lung cancer risk in Xuan Wei, China. Lung Cancer 49 (2005) 317-323
30. Cerosaletti K.M., and Concannon P. Nibrin forkhead-associated domain and breast cancer C-terminal domain are both required for nuclear focus formation and phosphorylation. J Biol Chem 278 (2003) 21944-21951
31. Försti A., Angelini S., Festa F., et al. Single nucleotide polymorphisms in breast cancer. Oncol Rep 11 (2004) 917-922
32. Ryk C., Kumar R., Thirumaran R.K., and Hou S.M. Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers. Lung cancer 54 (2006) 285-292
33. Ryk C., Kumar R., Sanyal S., et al. Influence of polymorphism in DNA repair and defence genes on p53 mutations in bladder tumours. Cancer Lett 241 (2006) 142-149
34. Bork P., Hofmann K., Bucher P., Neuwald A.F., Altschul S.F., and Koonin E.V. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J 11 (1997) 68-76
35. Kobayashi J., Tauchi H., Sakamoto S., et al. NBS1 localizes to gamma-H2AX foci through interaction with the FHA/BRCT domain. Curr Biol 12 (2002) 1846-1851